Earnings Per Common Share (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of Computation of Basic and Diluted Earnings per Share

The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):


	Three Months Ended March 31,
	2022		2021
Numerator
Income (loss) from continuing operations	$	75,026	$	(120,585)
Noncontrolling interests' share in continuing operations	(3,730)		(3,306)
Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.	71,296		(123,891)
Less: Participating securities' share in continuing operations	(1,976)		(2,451)
Income (loss) from continuing operations applicable to common shares	69,320		(126,342)
Income (loss) from discontinued operations	317		270,008
Noncontrolling interests' share in discontinued operations	—		(329)
Net income (loss) applicable to common shares	$	69,637	$	143,337




Denominator
Basic weighted average shares outstanding	539,352		538,679
Dilutive potential common shares - equity awards(1)	234		—


Diluted weighted average common shares	539,586		538,679
Basic earnings (loss) per common share
Continuing operations	$	0.13	$	(0.23)
Discontinued operations	0.00		0.50
Net income (loss) applicable to common shares	$	0.13	$	0.27
Diluted earnings (loss) per common share
Continuing operations	$	0.13	$	(0.23)
Discontinued operations	0.00		0.50
Net income (loss) applicable to common shares	$	0.13	$	0.27

_______________________________________

(1)For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options).

For the three months ended March 31, 2022, the 9.1 million shares under forward sales agreements that have not been settled as of March 31, 2022 were anti-dilutive. For the three months ended March 31, 2021, forward sales agreements had no dilutive impact as no shares remained outstanding under ATM forward contracts during the period.